RM 101-1702 ADLi Institute, AZothBio. Inc., 109 Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea.
RM D-724 Hyundai Knowledge Industry Center, AZothBio. Inc., 520 Misa-daero, Hanam-si 12927, Republic of Korea.
Biomolecules. 2023 Mar 13;13(3):522. doi: 10.3390/biom13030522.
Cell-penetrating peptides (CPPs) have great potential to deliver bioactive agents into cells. Although there have been many recent advances in CPP-related research, it is still important to develop more efficient CPPs. The development of CPPs by in silico methods is a very useful addition to experimental methods, but in many cases it can lead to a large number of false-positive results. In this study, we developed a deep-learning-based CPP prediction method, AiCPP, to develop novel CPPs. AiCPP uses a large number of peptide sequences derived from human-reference proteins as a negative set to reduce false-positive predictions and adopts a method to learn small-length peptide sequence motifs that may have CPP tendencies. Using AiCPP, we found that short peptide sequences derived from amyloid precursor proteins are efficient new CPPs, and experimentally confirmed that these CPP sequences can be further optimized.
细胞穿透肽 (CPPs) 在将生物活性物质递送入细胞方面具有巨大的潜力。尽管最近在 CPP 相关研究方面取得了许多进展,但开发更有效的 CPP 仍然很重要。通过计算方法开发 CPP 是对实验方法的很好补充,但在许多情况下,它可能会导致大量假阳性结果。在这项研究中,我们开发了一种基于深度学习的 CPP 预测方法 AiCPP,用于开发新型 CPP。AiCPP 使用大量源自人类参考蛋白的肽序列作为负集,以减少假阳性预测,并采用一种学习可能具有 CPP 倾向的小长度肽序列基序的方法。使用 AiCPP,我们发现源自淀粉样前体蛋白的短肽序列是有效的新型 CPP,并通过实验证实这些 CPP 序列可以进一步优化。